Paper41449244
Inhibin beta A drives colorectal cancer progression through macrophage M2 polarization and mitochondria-dependent ferroptosis suppression.
Li W and 7 others. Signal Transduct Target Ther, 2025. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Inhibin beta A drives colorectal cancer progression through macrophage M2 polarization and mitochondria-dependent ferroptosis suppression. Papers, record 41449244. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41449244
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inhibin beta A drives colorectal cancer progression through macrophage M2 polarization and mitochondria-dependent ferroptosis suppression.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ferroptosis | Major topic |
| Colorectal Neoplasms | Major topic |
| Mitochondria | Major topic |
| Macrophages | Major topic |
| Tumor-Associated Macrophages | Major topic |
| Humans | |
| Tumor Microenvironment | |
| Animals | |
| Mice | |
| Disease Progression | |
| Cell Line, Tumor | |
| Gene Expression Regulation, Neoplastic |
Source PubMed
References58
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20926807 | Activin A balances Sertoli and germ cell proliferation in the fetal mouse testis. | Biol Reprod | 2011 | https://conductscience.org/library/papers/20926807 | PubMed |
| 2 | 33591350 | Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review. | JAMA | 2021 | https://conductscience.org/library/papers/33591350 | PubMed |
| 3 | 30096309 | Krebs Cycle Reimagined: The Emerging Roles of Succinate and Itaconate as Signal Transducers. | Cell | 2018 | https://conductscience.org/library/papers/30096309 | PubMed |
| 4 | 34102574 | Elucidating the contribution of mitochondrial glutathione to ferroptosis in cardiomyocytes. | Redox Biol | 2021 | https://conductscience.org/library/papers/34102574 | PubMed |
| 5 | 30222970 | Metformin downregulates the mitochondrial carrier SLC25A10 in a glucose dependent manner. | Biochem Pharmacol | 2018 | https://conductscience.org/library/papers/30222970 | PubMed |
| 6 | 37446354 | Extracellular Succinate: A Physiological Messenger and a Pathological Trigger. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37446354 | PubMed |
| 7 | 34650049 | Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53. | Cell Death Dis | 2021 | https://conductscience.org/library/papers/34650049 | PubMed |
| 8 | 34346300 | Inhibin β-A (INHBA) induces epithelial-mesenchymal transition and accelerates the motility of breast cancer cells by activating the TGF-β signaling pathway. | Bioengineered | 2021 | https://conductscience.org/library/papers/34346300 | PubMed |
| 9 | 36797289 | TRIM21 inhibits irradiation-induced mitochondrial DNA release and impairs antitumour immunity in nasopharyngeal carcinoma tumour models. | Nat Commun | 2023 | https://conductscience.org/library/papers/36797289 | PubMed |
| 10 | 34439114 | The Multifaceted Role of TGF-β in Gastrointestinal Tumors. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34439114 | PubMed |
| 11 | 34103052 | An immune-related model based on INHBA, JAG2 and CCL19 to predict the prognoses of colon cancer patients. | Cancer Cell Int | 2021 | https://conductscience.org/library/papers/34103052 | PubMed |
| 12 | 38373649 | Targeting lipid metabolism of macrophages: A new strategy for tumor therapy. | J Adv Res | 2025 | https://conductscience.org/library/papers/38373649 | PubMed |
| 13 | 34707288 | SLC25A39 is necessary for mitochondrial glutathione import in mammalian cells. | Nature | 2021 | https://conductscience.org/library/papers/34707288 | PubMed |
| 14 | 38588888 | INHBA regulates Hippo signaling to confer 5-FU chemoresistance mediated by cellular senescence in colon cancer cells. | Int J Biochem Cell Biol | 2024 | https://conductscience.org/library/papers/38588888 | PubMed |
| 15 | 15329331 | Developmental profiles of activin betaA, betaB, and follistatin expression in the zebrafish ovary: evidence for their differential roles during sexual maturation and ovulatory cycle. | Biol Reprod | 2004 | https://conductscience.org/library/papers/15329331 | PubMed |
| 16 | 31735641 | Cancer-Derived Succinate Promotes Macrophage Polarization and Cancer Metastasis via Succinate Receptor. | Mol Cell | 2020 | https://conductscience.org/library/papers/31735641 | PubMed |
| 17 | 38252148 | FOXA2-initiated transcriptional activation of INHBA induced by methylmalonic acid promotes pancreatic neuroendocrine neoplasm progression. | Cell Mol Life Sci | 2024 | https://conductscience.org/library/papers/38252148 | PubMed |
| 18 | 37904170 | M2 macrophage-secreted exosomes promote metastasis and increase vascular permeability in hepatocellular carcinoma. | Cell Commun Signal | 2023 | https://conductscience.org/library/papers/37904170 | PubMed |
| 19 | 38676428 | Positive GLI1/INHBA feedback loop drives tumor progression in gastric cancer. | Cancer Sci | 2024 | https://conductscience.org/library/papers/38676428 | PubMed |
| 20 | 31631858 | Colorectal cancer. | Lancet | 2019 | https://conductscience.org/library/papers/31631858 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42977749 | Therapy-induced tumour senescence drives oxaliplatin resistance via ADORA1-dependent palmitic acid metabolic reprogramming in colorectal cancer. | Oncogene | 2026 | https://conductscience.org/library/papers/42977749 | PubMed |
| 42807916 | Protein Post-Translational Modifications in the Regulation of Ferroptosis: New Opportunities and Challenges for Cancer Immunotherapy. | Int J Biol Sci | 2026 | https://conductscience.org/library/papers/42807916 | PubMed |
| 42737827 | Sucnr1 Mediates Leukocyte-Endothelial Cell Interactions Induced by Tnfα. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42737827 | PubMed |
| 42724741 | Remodeling the tumor immune microenvironment: mechanisms of crosstalk between regulated cell death macrophages. | Front Immunol | 2026 | https://conductscience.org/library/papers/42724741 | PubMed |
| 42530712 | Colorectal cancer-derived exosomal ETS2 promotes macrophage M2 polarization by transcriptionally activating PRPF4. | Hum Cell | 2026 | https://conductscience.org/library/papers/42530712 | PubMed |
| 42481820 | Redefining breast cancer: therapeutic opportunities in HER2-low and emerging molecular subtypes. | Clin Transl Oncol | 2026 | https://conductscience.org/library/papers/42481820 | PubMed |
| 42377012 | Immune Gene INHBA is Associated With Osteoarthritic Cartilage Damage and May Mediate the Temporal Activation of the TGF-β/p38 MAPK Pathway: Integrating Multiomics Machine Learning and Experimental Validation. | Mediators Inflamm | 2026 | https://conductscience.org/library/papers/42377012 | PubMed |
| 42370143 | Integrative single-cell and bulk transcriptomic analyses identify DRAM1 as a candidate gene from fibroblast-associated transcriptional programs in colorectal cancer. | Front Oncol | 2026 | https://conductscience.org/library/papers/42370143 | PubMed |
| 42319552 | An epithelial mesenchymal transition associated gene signature stratifies risk of ulcerative colitis associated colorectal cancer. | Discov Oncol | 2026 | https://conductscience.org/library/papers/42319552 | PubMed |
| 42205202 | Ubiquitination and N6-methyladenosine in cancer: Convergent regulation of oncogenic signaling pathways (Review). | Oncol Lett | 2026 | https://conductscience.org/library/papers/42205202 | PubMed |
| 42109353 | A review on angio-fibrotic pathways driving cancer potential in oral submucous fibrosis. | Bioinformation | 2026 | https://conductscience.org/library/papers/42109353 | PubMed |
| 41989643 | Aberrant expression of TRIM26 suppresses ferroptosis through regulating GPX4 protein stability in colorectal cancer. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/41989643 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GPX4 | 2879 | PubTator's text mining | https://conductscience.org/library/genes/2879 | NCBI Gene |
| INHBA | 3624 | PubTator's text mining | https://conductscience.org/library/genes/3624 | NCBI Gene |
| MUL1 | 79594 | PubTator's text mining | https://conductscience.org/library/genes/79594 | NCBI Gene |
| SLC25A10 | 1468 | PubTator's text mining | https://conductscience.org/library/genes/1468 | NCBI Gene |
| SUCNR1 | 56670 | PubTator's text mining | https://conductscience.org/library/genes/56670 | NCBI Gene |
| TRIM21 | 6737 | PubTator's text mining | https://conductscience.org/library/genes/6737 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41449244
GET https://conductscience.org/api/papers/v1/41449244/references?page=2